Home | Business News | Browse by Publication | B | Business Wire

DiscoveRx Signs a Worldwide Agreement with GlaxoSmithKline (GSK) that Allows GSK Access to PathHunter[TM] U-Arrestin Cell lines and Reagents for G-PCR Screening.

Publication: Business Wire
Publication Date: 01-OCT-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
FREMONT, Calif. -- DiscoveRx Corp. announced today the signing of a global agreement with GSK, a leading pharmaceutical company, to provide access to its PathHunter[TM] U-Arrestin parental cell lines, clones and associated reagents for use in GSK's internal GPCR Screening and Profiling efforts. The agreement was announced soon after...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Business Wire
Fiserv Launches Acumen[TM]: New Account Processing Solution for Credit..., October 01, 2009
USC Lusk Center for Real Estate Economists Offer Real-Time Insights on..., October 01, 2009
O'Charley's Names Wilson L. Craft O'Charley's Concept President., October 01, 2009
Do Good to Get Goods: Buy TheBigBundle for $30 and Get More Than $700 ..., October 01, 2009
Four TBC Global News Network Programs Enter Post-Production., October 01, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.